Error Correction

    January 2003 in “ Piel ”
    Image of study
    TLDR The document corrects a mistake by stating that pimecrolimus, not tacrolimus, is the drug that concentrates in the skin.
    The document acknowledges an error in a previously published article titled "Pimecrolimus. Pharmacology and preclinical studies" in the journal Piel, specifically in the caption of figure 8. The error pertained to the incorrect naming of a drug; where "tacrolimus" was mentioned, it should have been "pimecrolimus." The corrected figure caption is provided, indicating that pimecrolimus, not tacrolimus, preferentially distributes in the skin according to pharmacokinetic data from an experimental study involving oral doses of 25 mg/kg in rats, with concentrations measured 6 hours after the second dose. The figure shows the tissue concentration ratio of pimecrolimus to tacrolimus.
    Discuss this study in the Community →

    Related Community Posts Join

    2 / 2 results

      community I always hear the advice to reduce scalp inflammation. What are some non-steroidal ways to reduce inflammation?

      in Treatment  13 upvotes 6 months ago
      Non-steroidal ways to reduce scalp inflammation include using topical melatonin, urea shampoo, Zyrtec, turmeric with black pepper, omega-3 supplements, a self-made topical solution with cetirizine, melatonin, and piroctone olamine, ketoconazole shampoo, witch hazel shampoo, tacrolimus, and lifestyle changes like a healthy diet and regular exercise. Some users also mentioned unconventional methods like infrared light therapy and a carnivore diet.
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  830 upvotes 1 year ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

    Similar Research

    5 / 318 results